Classification Categories for Certain Supplements Under BsUFA III
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
September 8, 2025
September 8, 2025
66d51a68-e6a8-4e86-8097-7ddf219d36b9
Related Documents
Bioanalytical Method Validation for Biomarkers
Guidance DocumentApril 10, 2026Center for Drug Evaluation and Research
E6(R3) Good Clinical Practice (GCP)
Guidance DocumentSeptember 8, 2025Center for Drug Evaluation and Research
Development of Therapeutic Protein Biosimilars: Comparative Analytical Assessment and Other Quality-Related Considerations Guidance for Industry
Guidance DocumentSeptember 9, 2025Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.